CAMBRIDGE, England and BOSTON, May 22, 2017 /PRNewswire/ -- Leading NLP text analytics provider Linguamatics today announced plans to highlight the latest version of its text mining platform at this week's Bio-IT World Conference & Expo in Boston. Bio-IT World has named Linguamatics I2E 5.0 a contender for the Best of Show Award, and Linguamatics' customer Pentavere Research Group a Best Practices finalist.
The Best of Show Awards showcase exceptional innovation in technologies used by life science professionals. As a Best of Show Award contender, Linguamatics is also eligible for the Bio-IT World People's Choice Award, chosen by votes from the Bio-IT World Community. Voting for the People's Choice Award is open from 5 pm ET Tuesday May 23 through 1 pm ET on Wednesday May 24.
Bio-IT World also chose Linguamatics customer Pentavere Research Group as a Best Practices finalist, based on their work using I2E to mine unstructured data for real-world evidence to improve health outcomes. Best Practices finalists are recognized for their outstanding examples of technology innovation, from basic R&D to translational medicine. Pentavere deployed I2E to effectively mine unstructured EHR data, expediting delivery of their product daRWEn™ to the Real World Evidence market.
"The annual Bio-IT World Conference & Expo is a premier event in the life sciences industry and we are honored to be considered a Best of Show Award contender," said Phil Hastings, Linguamatics chief business development officer. "We are also proud to feature in the Best Practices awards program through Pentavere's use of I2E, and congratulate them for being named a finalist."
Since its debut in 2002, the Bio-IT World Conference & Expo has showcased the myriad of IT and informatics technologies that drive biomedical research, drug discovery and development, and clinical and healthcare initiatives. This year marks Linguamatics' 12th consecutive year as a conference participant and exhibitor.
The 2017 conference features over 200 technology and scientific track sessions, including a presentation by Linguamatics CTO David Milward, Ph.D., on Wednesday May 24 at 12pm ET. During the Clinical Research and Translational Informatics track, Dr. Milward will discuss how text mining extracts and connects relevant clinical and scientific data in a session entitled, "Text Mining in Translational Research: Bench to Bedside and Back Again." During his talk Dr. Milward will highlight Eli Lilly's use of I2E for systematic drug repositioning from clinical trial records.
Linguamatics Life Science platform uses advanced NLP to transform unstructured text into structured data. I2E 5.0 provides major new enhancements, including powerful concept normalization, advanced range search, and a new query language. These capabilities tackle the variety in big data to provide insights from the estimated 80% of data trapped in unstructured text, as well as from semi-structured and structured data sources.
Linguamatics will provide demonstrations of its new I2E 5.0 release at Booth 345.
About Linguamatics
Linguamatics transforms unstructured big data into big insights to advance human health and wellbeing. A natural language processing (NLP)-based text mining leader, Linguamatics' solutions are used by top commercial, academic and government organizations for high-value knowledge discovery and decision support, including 18 of the top 20 global pharmaceutical companies and leading US healthcare organizations.
Linguamatics I2E mines a wide variety of text resources, including scientific literature, patents, Electronic Health Records (EHRs), clinical trials data, news feeds and proprietary content. I2E can be deployed as an in-house enterprise system or as Software-as-a-Service (SaaS).
Linguamatics Media contact:
Michelle Ronan Noteboom, Sr. Account Director
Amendola Communications
+ 1 512.426.2870
mnoteboom@acmarketingpr.com
SOURCE Linguamatics